ABBOTT PARK, Ill., Sept. 15 /PRNewswire/ -- Abbott announced today it has been named the overall Gold winner of the 2009 Wall Street Journal Technology Innovation Awards for its Ibis T5000 Biosensor system, which is designed to detect and characterize a broad range of infectious agents in a given sample, including viruses, bacteria and fungi.
Abbott's Ibis system (now marketed under the PLEX-ID trade name) was singled out for the top honor, in part, because it promises to alert health officials to new disease strains, and may also guard against bioterrorism and enable hospitals to identify antibiotic-resistant bacteria in its environment.
The PLEX-ID is a high-throughput technology based on a combination of molecular technologies, including polymerase chain reaction (PCR) and mass spectrometry analysis. The system is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as required with current culturing methods.
About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.
Abbott
